In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS
Autor: | Milanese, M., Torazza, C., Provenzano, F., Bonifacino, T., Ravera, S., Balbi, M., Frumento, G., Kumar, M., Cerminara, M., Puliti, A., Usai, C., Bonanno, G. |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Databáze: | OpenAIRE |
Externí odkaz: |